Latest Breaking News On - D christopher metzger - Page 1 : comparemela.com

InspireMD Announces Presentation of Positive One-Year

Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection.

New Carotid Stent Systems Associated With Low Stroke Risk

With complication rates of 1% or less, Neuroguard and CGuard are renewing optimism about CAS, experts said at VIVA 2023.

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA23

First-on-Podium Data from 20 Vascular and Venous Clinical Trials to Be Presented at The VEINS and VIVA 2023

First-on-Podium Data from 20 Vascular and Venous Clinical Trials to Be Presented at The VEINS and VIVA 2023

/PRNewswire/ Leading physicians and researchers will present results from 20 clinical trials from Monday, October 30, to Wednesday, November 1, at the.